US Pharma MarketingRegulatory round-up: A month of key FDA approvals for cancer drugs - Pharmaceutical Technology
Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications. Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications. The FDA has approved four oncology drugs thus far in May 2026. Credit: Ashley Grise / Shutterstock.com. It has been a big month for the oncology space, underpinned by several US approvals in haematological and solid tumour indications – with BeOne Medicines, Taiho Oncology and Arvinas all securing the regulatory greenlight for their respective cancer drugs. In the haematology space,…
Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications.
Source: Pharmaceutical Technology